BackBlueprint Medicines Overview

Blueprint Medicines Total Revenue

Revenue analysis for BPMC.

Quarterly Revenue

$149.41M
↑ 55.45% YoY

As of Mar 2025

Annual Revenue (TTM)

$562.12M
↑ 99.19% YoY

Trailing 12 months ending Mar 2025

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin